This is the first human cancer vaccine study to see T-cell responses in the absence of B-cells. This paves the way to use vaccines in a number of hematological cancers that are treated by eliminating diseased B-cells.
This paves the way to use vaccines in a number of hematological cancers that are treated by eliminating diseased B cells.
After the third vaccination, we began to see T-cell responses. An antibody response to the tumor produced by recovering B cells was seen after the fourth or fifth vaccination.
